Triumph Capital Management’s Moderna MRNA Stock Holding History

Triumph Capital Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$7.75K	Buy
2022 Q3	–	Sell
2022 Q2	$572K	Sell
2022 Q1	$692K	Buy